Literature DB >> 10842773

Characteristics of Caucasian type 2 diabetic patients during ketoacidosis and at follow-up.

N Pitteloud1, J Philippe.   

Abstract

OBJECTIVE: To analyse among adult Caucasian patients hospitalised for diabetic ketoacidosis the relative frequency of patients with type 2 diabetes and their characteristics. RESEARCH
DESIGN: A retrospective review of adult patients presenting with diabetic ketoacidosis was conducted between 1993 and 1996. Patients with typical type 1 diabetes were classified according to age of onset < 35 years, insulin-dependence and BMI < 25 kg/m2; patients who did not meet these criteria were further classified on the basis of a basal and stimulated C-peptide and the detection of antibodies to glutamic acid decarboxylase (GADA) and to islet cells (ICA).
RESULTS: 43 patients presenting with an episode of diabetic ketoacidosis were divided into two groups, A and B. Group A consisted of 19 patients, 17 patients classified as patients with typical type 1 diabetes and 2 patients with diabetes post-pancreatectomy. The other patients were the subjects of our study (group B; n = 20, 4 lost to follow-up). 13 patients (65% of group B = B I) were diagnosed with type 1 diabetes (median basal C-peptide: 0.15 nmol/l) and 7 patients (35% of group B = B II) with type 2 diabetes (median basal C-peptide of 1 nmol/l). Higher body mass index (BMI), shorter duration of diabetes, smaller anion gap and worse glycaemic control were found to be significantly different between groups B I and II on admission (p < 0.05). After a median follow-up of 18 months, patients in group B II had a better metabolic control than those in B I and 5 of the 7 patients were treated without insulin.
CONCLUSION: Diabetic ketoacidosis is more common than previously thought in patients with type 2 diabetes, occurring in 16% of all cases. Distinctive features at presentation are the degree of acidosis, the duration of diabetes, BMI and HbA1c. However, the basal plasma C-peptide value remains the best discriminating factor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10842773

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  5 in total

1.  Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of "A-β+" ketosis-prone diabetes based on long-term β-cell function, human leukocyte antigen class II alleles, and sex predilection.

Authors:  Ramaswami Nalini; Kerem Ozer; Mario Maldonado; Sanjeet G Patel; Christiane S Hampe; Anu Guthikonda; Jesus Villanueva; E O'Brian Smith; Lakshmi K Gaur; Ashok Balasubramanyam
Journal:  Metabolism       Date:  2010-02-19       Impact factor: 8.694

Review 2.  Body mass index and outcomes from pancreatic resection: a review and meta-analysis.

Authors:  Andrew M Ramsey; Robert C Martin
Journal:  J Gastrointest Surg       Date:  2011-04-12       Impact factor: 3.452

Review 3.  Syndromes of ketosis-prone diabetes mellitus.

Authors:  Ashok Balasubramanyam; Ramaswami Nalini; Christiane S Hampe; Mario Maldonado
Journal:  Endocr Rev       Date:  2008-02-21       Impact factor: 19.871

Review 4.  Toward an Improved Classification of Type 2 Diabetes: Lessons From Research into the Heterogeneity of a Complex Disease.

Authors:  Maria J Redondo; Ashok Balasubramanyam
Journal:  J Clin Endocrinol Metab       Date:  2021-11-19       Impact factor: 6.134

5.  Incidence and outcome of adults with diabetic ketoacidosis admitted to ICUs in Australia and New Zealand.

Authors:  Balasubramanian Venkatesh; David Pilcher; John Prins; Rinaldo Bellomo; Thomas John Morgan; Michael Bailey
Journal:  Crit Care       Date:  2015-12-29       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.